Company reaffirms $3.18B-$3.22B revenue guidance for Q1 2026 while projecting higher earnings per share.
Globus Medical announced a non-GAAP earnings per share target of $4.70-$4.80 for Q1 2026, reflecting margin expansion and operational discipline. The company also reaffirmed its revenue guidance of $3.18 billion to $3.22 billion for the period.
First-quarter results demonstrated growth through market share capture and scaling efforts. The EPS projection aligns with prior expectations, while revenue guidance remains unchanged from earlier forecasts.
Management highlighted ongoing focus on efficiency and share gains as key drivers for the outlook.